E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 3.17 EUR 0.32%
Market Cap: 303m EUR
Have any thoughts about
Euroapi SAS?
Write Note

Gross Margin
Euroapi SAS

17%
Current
17%
Average
48.5%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
17%
=
Gross Profit
165.5m
/
Revenue
971.3m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
FR
Euroapi SAS
PAR:EAPI
302m EUR
17%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-3%
US
Eli Lilly and Co
NYSE:LLY
747.7B USD
81%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
DK
Novo Nordisk A/S
CSE:NOVO B
2.8T DKK
85%
US
Johnson & Johnson
NYSE:JNJ
342.5B USD
69%
US
Merck & Co Inc
NYSE:MRK
252.8B USD
77%
CH
Roche Holding AG
SIX:ROG
216.7B CHF
73%
UK
AstraZeneca PLC
LSE:AZN
170.3B GBP
82%
CH
Novartis AG
SIX:NOVN
179.3B CHF
75%
US
Pfizer Inc
NYSE:PFE
152.2B USD
71%
No Stocks Found

Euroapi SAS
Glance View

Market Cap
302m EUR
Industry
Pharmaceuticals

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

EAPI Intrinsic Value
4.89 EUR
Undervaluation 35%
Intrinsic Value
Price
E
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
17%
=
Gross Profit
165.5m
/
Revenue
971.3m
What is the Gross Margin of Euroapi SAS?

Based on Euroapi SAS's most recent financial statements, the company has Gross Margin of 17%.

Back to Top